Latest News

Preliminary clinical study results show improvement in MS symptoms

Combining the estrogen hormone estriol with Copaxone, a drug indicated for the treatment of patients with relapsing forms of multiple sclerosis, may improve symptoms in patients with the disorder, according to preliminary results from a clinical study of 158 patients with relapsing remitting multiple sclerosis.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Death of a parent during childhood is associated with greater mortality in early adulthood

  • The 92 percent clean plate club: You're not alone in eating everything on your plate

  • Wide-faced men negotiate nearly ,200 larger signing bonus

  • How stress hormones promote brain's building of negative memories

  • Why do challenging tasks make consumers believe drugs wear off faster?

  • Empathy or justice: What makes consumers donate more to charity?

  • I?ll have what he's having? How consumers make choices about new products

  • Retail pricing strategies: Do consumers prefer Deep Discounts or Everyday Low Prices?

  • Clients of violence interventional advocacy program find experience supportive

  • Potential Genetic Link Between Epilepsy, Neurodegenerative Disorders

  •